Technology for measuring excitation-contraction coupling in hiPSC heart tissue optimises drug development
Companymyotwin GmbH, Goettingen, Germany
The myotwin technology developed by the company myotwin enables the analysis of all relevant parameters of the excitation-contraction coupling of heart muscle tissue derived from hiPSCs. This non-invasive measurement enables sterile long-term analysis of electrophysiology, calcium oscillation and contractility over several months. A high degree of automation throughout the entire test cycle ensures high reproducibility and fully automated documentation. Myotwin is a valuable tool for efficacy and toxicity testing, as its use can reduce the risk of potential drug-related side effects and speed up the drug development process.
Mimicking the human heart is essential for high translatability
hello@myotwin.com
Added on: 10-23-2024
[1] https://myotwin.com/#technology